AMY MERRILL: Open Payments
NPI 1558726935 · ROANOKE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 15 payments from 9 companies in 2025. Trend: 2023 $14 · 2024 $15 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $63 |
| Axsome Therapeutics, Inc. | 2 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Novo Nordisk Inc | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Valinor Pharma, LLC | 1 | $14 |
Products named: VRAYLAR, Auvelity, Kerendia, JARDIANCE, CAPLYTA, Wegovy, MOUNJARO, GEMTESA.
Industry payments across AL — which companies pay providers there.
